These results provide new insights into the molecular mechanisms of maspin deficiency in response to HBx, and suggest a positive maspin expression and low maspin-targeting microRNAs serving as biomarkers for better prognosis of HBV-associated HCC patients. This evidence concerns the gene SERPINB5 and hepatocellular carcinoma.